Robert L. Rosiello - 16 Nov 2022 Form 4 Insider Report for Axcella Health Inc.

Role
Director
Signature
By: /s/ Paul Fehlner, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Nov 2022
Net transactions value
$0
Form type
4
Filing time
18 Nov 2022, 15:15:53 UTC
Previous filing
17 Oct 2022
Next filing
18 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 16 Nov 2022 Common Stock 40,000 $0.9900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in twelve equal quarterly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.